Jean-Charles Fruchart Prize in Nuclear Receptors and Atherosclerosis Research
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Overview
Funder: International Atherosclerosis Society (DC, US) and R3i Foundation
Recognition: Prize for outstanding research in nuclear receptors and atherosclerosis
Award Criteria: Recognizes outstanding scientific, medical or organizational advancement in the ability to understand the functional involvement of nuclear receptors in atherosclerotic vascular disease and their athero-protective role to reduce the development of atherosclerosis.
Scope: International recognition
Recent Award Recipients
- 2024 (2nd Prize): Peter Tontonoz, MD, PhD - Awarded at the 20th International Symposium on Atherosclerosis (ISA2024) in Muscat, Oman
- 2021 (1st Prize): Hitoshi Shimano, MD, PhD - Clinical professor of the Department of Internal Medicine, Metabolism and Endocrinology at the University of Tsukuba, Japan. Awarded at ISA2021 in Kyoto, Japan
Sponsorship: Sponsored by the R3i Foundation and the International Atherosclerosis Society
What International Atherosclerosis Society actually gave
Source: IRS Form 990, 2020 — the most recent filing with itemized grants
International Atherosclerosis Society reported $6,385 in grants for 2024 as a total without an itemized list; the grant details below are from 2020, its most recent itemized filing.
- Grants in 2020
- 1
- Total given
- $10K
- Median grant
- $10K
- By dollars: New York 100%. Top recipient cities: New York, NY.
Example grants
American Austrian Foundation · New York, NY
Education grant
$10K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Heart disease
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
National Institutes of Health
Amount
$4,500,000 total
Deadline
March 10, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
National Institutes of Health
Amount
Up to $1,515,000
Deadline
January 7, 2027
DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$1,600,000 total
Deadline
November 12, 2026
DoW Vision, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$4,400,000 total
Deadline
November 12, 2026
Astronomy and Astrophysics Research Grants
U.S. National Science Foundation
Amount
$50,000,000 total
Deadline
November 16, 2026
DoW Orthopaedic, Clinical Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$13,600,000 total
Deadline
November 18, 2026
Ready to apply for Jean-Charles Fruchart Prize in Nuclear Receptors and Atherosclerosis Research?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Jean-Charles Fruchart Prize in Nuclear Receptors and Atherosclerosis Research. Now let's win it.